You just read:

New Presentations at ATS 2016 Reinforce OFEV® (nintedanib) Efficacy, Safety and Tolerability Across Range of Patients with IPF

News provided by

Boehringer Ingelheim Pharmaceuticals, Inc.

May 16, 2016, 08:00 ET